VIP Membership
Description
-
Ordered
- - -
Order Ready
- - -
Delivered
Description
This advanced tri-compound tablet combines SLU-PP-332, 5-Amino-1MQ, and BPC-157, offering a versatile formulation for researchers investigating pathways related to energy metabolism, cellular signaling, and tissue repair. Each compound has been studied independently in preclinical models, and this blend allows for the exploration of potential synergistic effects across metabolic and regenerative research domains.
Blend Composition (Per Tablet):
- SLU-PP-332 – 0.25mg
- 5-Amino-1MQ – 25mg
- BPC-157 – 0.125mg
- 90 tablets per bottle
Key Characteristics:
- SLU-PP-332: AMPK pathway modulator studied in metabolic and endurance research
- 5-Amino-1MQ: Small molecule investigated for its role in NNMT inhibition and metabolic enhancement
- BPC-157: Synthetic peptide fragment examined in models of injury recovery and inflammation modulation
- Convenient oral delivery system designed for stable research handling
- Consistent compound ratios for controlled dosing in experimental setups
Intended Use:
Certificate of Anaylsis (COA)
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
You May Also Like
Related products
Epithalon (50mg)
Dihexa/Tesofensine/BPC-157 (10/0.25/0.125mg) x 60 Tablets
CJC-1295 – No DAC (10mg)
Follistatin 344 (95%) (1mg)
Hexarelin (5mg)
Additional information
| Trial | 10 Day Wholesale Access |
|---|
There are no question found.
Rating & Review
There are no reviews yet.